why choose us

First received: February 09, 2024

Clinical Trial: Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Ulcerative Colitis

Study Type: OBSERVATIONAL


Official Title: Comparison of Short and Long-term Efficacy Between Infliximab and Adalimumab on Patients With Ulcerative Colitis - a Retrospective Observational Multicenter Cohort Study

Brief Summary: Anti-TNF (tumor necrosing factor) treatment with infliximab (IFX) and adalimumab (ADA) are established first-line biological therapies used in treatment of patients with ulcerative colitis (UC).There are no head-to-head comparative studies between these two drug but meta-analysis of randomized controlled trials states that IFX might be more effective than ADA for the induction of clinical remission.However, several observational studies conclude that ADA seem to have similar effect as IFX in treating patients with…

Read more